SILO PHARMA INC (SILO)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · SILO
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 293.4% |
| Our one-year growth estimate | diamond | -0.1% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 293.5 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 66 industry peers
SILO — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-10-14
Unregistered Sales of Equity Securities. The information set forth under
Why it matters: Silo announced three software or technology purchases, with stock issued for the assets. Filings that name the assets and their use can show what the deals add.
Watch forA company filing names the software assets and explains how QwikAgents uses them. It reports a working product or customer use.
Also watch forA company filing says the assets were not used or were written down. Or they led to more shares without a stated business use.
Why it matters: The placement brings in cash for working capital, but it also adds shares and warrants. Check that the deal closes and the resale filing is made.
Watch forA company filing confirms the placement closed. It also says the resale registration statement was filed with the SEC.
Also watch forA company filing says the placement did not close. Or, SEC filings show no resale registration statement.
Why it matters: Silo regained Nasdaq's minimum bid-price rule in June. Another notice would put listing compliance back in focus.
Worry ifNasdaq or a company filing says Silo again failed the minimum bid-price rule. Or it got a new compliance notice.
Less concerning ifA company filing confirms Silo still meets the rules and reports no new Nasdaq bid-price notice.
Why it matters: Silo said it was working toward a first-in-human trial for SPC-15. A firm start date would show progress on its lead drug.
Supportive ifThe Nov. 12 report or a later company filing gives a dated plan to start the SPC-15 first-in-human trial.
Worry ifThe report gives no trial start date, or says the trial plan has been delayed or paused.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$230 on $10,000 · ±2.3% | How much price usually moves either way. |
| Bad day | $903 loss on $10,000 · 9.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,869 loss on $10,000 · 88.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.